A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).	Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder	Recruiting	Phase 1 / Phase 2	2026-03-19		NCT05608681

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eupraxia Pharmaceuticals Inc.	1

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam UMC	Amsterdam	Netherlands	6
Aotearoa Clinical Trials	Papatoetoe	New Zealand	1
Campbelltown Private Hospital	Sydney	Australia	1
Capital Coast and Hutt	Lower Hutt	New Zealand	1
Cardiff and Vale University Health Board-Wales	Cardiff	United Kingdom	1
Coastal Digestive Health	Maroochydore	Australia	1
Eastern Health Box Hill	Box Hill	Australia	2
Erasmus University Medical Center	Holland	Netherlands	1
G.I. Research Institute	Vancouver	Canada	1
Mater Hospital Brisbane	Brisbane	Australia	1
McGill University Health Center	Montreal	Canada	8
Norfolk and Norwich University Hospital	Norwich	United Kingdom	2
Northern Hospital Epping	Epping	Australia	1
Princess Alexandra Hospital	Brisbane	Australia	7
Royal Adelaide Hospital	Adelaide	Australia	10
Royal Liverpool University Hospital	Liverpool	United Kingdom	12
Royal Melbourne Hospital	Parkville	Australia	4
St George's University of London	London	United Kingdom	1
The Alfred Hospital	Melbourne	Australia	7
University of Calgary	Calgary	Canada	17
UniversitätsSpital Zürich	Zurich	Switzerland	14
UoA - South Edmonton Gastroenterology Research Clinic	Edmonton	Canada	1
Waikato Hospital	Hamilton	New Zealand	15

Clinical trials